PHG Stock Recent News

July 3, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips' Executive Committee, reporting to Philips CEO Roy Jakobs.

Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, with a positive outlook for Stellantis' and Ferrari's businesses. Exor's NAV discount is close to record-high levels. This supports our buy rating target price.

June 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021.

Philips (PHG) boosts Diagnosis & Treatment on the back of Precision Diagnosis and Image-Guided Therapy businesses and an expanding partner base.

BARCELONA, Spain--(BUSINESS WIRE)--eDreams ODIGEO (‘The Company'), the world's leading travel subscription platform and one of Europe's largest e-commerce businesses, today announced that it has achieved record customer advocacy and satisfaction levels following the pivot to a subscription-led model. This is supported by millions of data points, including customer related KPIs1 that are included in the Company's Non-financial Statement that is independently verified by external auditors, ensuri.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Future Health Index (FHI) survey conducted by Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, explores the ongoing staffing and access challenges within the US healthcare system and the innovative solutions being used to address them. The ninth annual report, Better care for more people, demonstrates the pressures of staffing shortages and burnout on clinicians and their ability to deliver timely, high-quality care to patients.

June 18, 2024 Healthcare leaders indicate automation is crucial in addressing staff shortages, but staff remain skeptical Interest in Generative AI grows, with majority of health leaders investing in, or planning to invest in AI technologies to help reduce delays in patient care Amsterdam, the Netherlands– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its Future Health Index 2024 report: Better care for more people. Launched at HLTH Europe , the ninth annual FHI global report shows that healthcare leaders are turning to virtual care and AI-enabled innovation to address pressure due to workforce shortages, financial burdens, and growing demand.

June 17, 2024 Intuitive motorization for greater control and high-power (25 kW [1]) for state-of-the-art image quality supports complex vascular needs and a full range of clinical procedures Automated workflows contribute to greater flexibility and independence for clinicians, providing more time to focus on achieving the best possible outcomes for patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized , designed to help clinicians deliver high-quality care to more patients. Philips is partnering with its customers to improve productivity.

Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Teeth Whitening Systems Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In an in-depth analysis of the Dental Devices therapeutic area, industry experts have compiled a comprehensive review of the Teeth Whitening Systems market with projections through the year 2033.

Philips (PHG) boosts its Image-Guided Therapy portfolio with the Duo Venous Stent System, strengthening its Diagnosis & Treatment segment.